Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amicus Therapeutics (FOLD) Times Interest Earned (2016 - 2025)

Amicus Therapeutics' Times Interest Earned history spans 16 years, with the latest figure at $1.4 for Q4 2025.

  • For the quarter ending Q4 2025, Times Interest Earned rose 4.47% year-over-year to $1.4, compared with a TTM value of $0.71 through Dec 2025, up 41.63%, and an annual FY2025 reading of $0.71, up 41.63% over the prior year.
  • Times Interest Earned for Q4 2025 was $1.4 at Amicus Therapeutics, down from $2.93 in the prior quarter.
  • The five-year high for Times Interest Earned was $2.93 in Q3 2025, with the low at -$9.25 in Q1 2022.
  • Average Times Interest Earned over 5 years is -$2.54, with a median of -$1.87 recorded in 2024.
  • Year-over-year, Times Interest Earned soared 564.02% in 2024 and then crashed 168.48% in 2025.
  • Tracing FOLD's Times Interest Earned over 5 years: stood at -$8.84 in 2021, then surged by 56.83% to -$3.82 in 2022, then surged by 92.46% to -$0.29 in 2023, then soared by 564.02% to $1.34 in 2024, then rose by 4.47% to $1.4 in 2025.
  • Per Business Quant, the three most recent readings for FOLD's Times Interest Earned are $1.4 (Q4 2025), $2.93 (Q3 2025), and -$0.82 (Q2 2025).